Related Experiment Video
Updated: May 11, 2026
08:59
Defining Substrate Specificities for Lipase and Phospholipase Candidates
Published on: November 23, 2016
Using isoform-specific inhibitors to target lipid kinases
1Clinical Research and Human Biology Divisions, Fred Hutchinson Cancer Research Center, D2-100, 1100 Fairview Avenue North, Seattle, WA 98109, USA. jsimon@fhcrc.org
Cell
|May 23, 2006
Summary
Small molecule inhibitors reveal that p110alpha, a phosphoinositide 3-kinase (PI3-K) isoform, is crucial for insulin signaling. Blocking p110alpha and mTOR kinase activity limits glioma growth.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Phosphoinositide 3-kinase (PI3-K) signaling pathways regulate crucial cellular processes.
- Dysregulation of PI3-K signaling is implicated in various diseases, including cancer and metabolic disorders.
- Specific isoforms of PI3-K, such as p110alpha, play distinct roles in cellular functions.
Purpose of the Study:
- To conduct a detailed pharmacological analysis of the PI3-K family using small molecule inhibitors.
- To elucidate the specific role of PI3-K isoforms in insulin signaling.
- To investigate the therapeutic potential of inhibiting PI3-K and mTOR in glioma growth.
Main Methods:
- Utilized small molecule inhibitors for pharmacological analysis of the PI3-K family.
- Investigated the effects of inhibitors on insulin signaling pathways.
- Assessed the impact of combined p110alpha and mTOR inhibition on glioma cell proliferation.
Main Results:
- Identified p110alpha as a critical PI3-K isoform in mediating insulin signaling.
- Demonstrated that p110alpha plays a key role in the PI3-K pathway.
- Showed that inhibiting both p110alpha and mTOR kinase activity significantly limits glioma growth.
Conclusions:
- p110alpha is a critical mediator of insulin signaling.
- Targeting p110alpha and mTOR with small molecule inhibitors presents a potential therapeutic strategy for gliomas.
- Pharmacological dissection of PI3-K isoforms offers insights into their specific biological functions.
Related Concept Videos
01:42Phosphoinositides and PIPs
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...